Evidence map›Paper›PMID 25305056›Full record

ArticleEndocrine2015

Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib.

Vincenzo Marotta, Carolina Di Somma, Manila Rubino, Concetta Sciammarella, Roberta Modica, Luigi Camera, Michela Del Prete, Francesca Marciello, Valeria Ramundo, Luisa Circelli and 3 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Endocrine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vincenzo MarottaDepartment of Clinical Medicine and Surgery, Section of Endocrinology, Federico II University of Naples, Via S. Pansini 5, 80131, Naples, Italy, vinc.endo@libero.it.
Carolina Di Somma
Manila Rubino
Concetta Sciammarella
Roberta Modica
Luigi Camera
Michela Del Prete
Francesca Marciello
Valeria Ramundo
Luisa Circelli
Pasqualina Buonomano
Annamaria Colao
Antongiulio Faggiano

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsDisease ProgressionDrug Resistance, NeoplasmFemaleHumansIndolesIodine RadioisotopesMaleMiddle AgedNeoplasm MetastasisNiacinamidePhenylurea CompoundsPyrrolesSorafenibSunitinibThyroid NeoplasmsAntineoplastic AgentsIndolesIodine RadioisotopesNiacinamidePhenylurea CompoundsPyrrolesSorafenibSunitinib

Identifiers

PMID25305056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.